维普中文期刊产品整合服务
2篇 您的检索式:作者名="Turhan H."
    题名 作者 年代 出处 被引量
1冠状动脉血流缓慢的患者其血浆可溶性黏附分子ICAM-1、VCAM-1和E-选择素水平升高显示文摘Background: Inflammation has been reported to be a major contributing factor to many cardiovascular events. In the present study, we aimed to evaluate plasma soluble adhesion molecules; intercellular adhesion molecule-1(ICAM-1), vascular cell adhesion molecule-1(VCAM-1) and E-selectin as possible indicators of endothelial activation or inflammation in patients with slow coronary flow. Method: Study population included 17 patients with angiographically proven normal coronary arteries and slow coronary flow in all three coronary vessels(group I, 11 male, 6 female, mean age=48± 9 years), and 20 subjects with angiographically proven normal coronary arteries without associated slow coronary flow(group II, 11 male, 9 female, mean age=50± 8 years). Coronary flow rates of all patients and control subjects were documented by Thrombolysis In Myocardial Infarction frame count(TIMI frame count). All patients in group I had TIMI frame counts greater than two standard deviation above those of control subjects(group II) and, therefore, were accepted as exhibiting slow coronary flow. Serum levels of ICAM-1, VCAM-1, and E-selectin were measured in all patients and control subjects using commercially available ELISA kits. Results: Serum ICAM-1, VCAM-1, and E-selectin levels of patients with slow coronary flow were found to be significantly higher than those of control subjects with normal coronary flow(ICAM-1: 545± 198 ng/ml vs. 242± 113 ng/ml respectively, p< 0.001, VCAM-1: 2040± 634 ng/ml vs. 918± 336 ng/ml respectively, p< 0.001, E-selectin: 67± 9 ng/ml vs. 52± 8 ng/ml respectively, p< 0.001). Average TIMI frame count was detected to be significantly correlated with plasma soluble ICAM-1(r=0.550, p< 0.001), VCAM-1(r=0.569, p< 0.001) and E-selectin(r=0.443, p=0.006). Conclusion: Increased levels of soluble adhesion molecules in patients with slow coronary flow may be an indicator of endothelial activation and inflammation and are likely to be in the causal pathway leading to slow coronary flow.Turhan H. Saydam G. S. Erbay A. R. 杜媛(译) 孙凯(校) 2006世界核心医学期刊文摘(心脏病学分册)2006,2,8:6
2Aspirin: from a Historical Perspective显示文摘Murat Ugurlucan Ilker M. Caglar Fatma N. Turhan Caglar Sedat Ziyade Oguzhan Karatepe Yahya Yildiz Ertugrul Zencirci Funda Gungor Ugurlucan Ahmet H. Arslan Semra Korkmaz Ugur Filizcan Sertac Cicek 2012Recent Patents on Cardiovascular Drug Discovery2012,,1:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费